Evaluation of co-morbidity indices in patients admitted for Chronic Obstructive Pulmonary Disease

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 61, Issue 4, 2004, Pages 209-212

  Pinckney, Richard G ^a   O'Brien, R ^a   Piccirillo, J F ^b   Littenberg, B ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chronic obstructive; Co Morbidity; Prognosis; Pulmonary disease; Risk adjustment

Indexed keywords

ADULT; ADULT COMORBIDITY EVALUATION 27; AGE; AGED; ARTICLE; CHARLSON INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HOSPITAL ADMISSION; HUMAN; INFORMATION RETRIEVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PREDICTION; REGRESSION ANALYSIS; RELIABILITY; RISK ASSESSMENT; SMOKING; SOCIAL SECURITY; SURVIVAL; VALIDATION PROCESS;

EID: 18044376193     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2004.683     Document Type: Article

References (33)

1. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: A prospective study of 200 patients. NEJM 1969; 280: 397-404.
2. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
3. Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156: 814-818.
4. Wijnhiven HA, Kriegsman DM, Hesselink AE, De Hann M, Schellevis FG. The influence of co-morbidity on health -related quality of life in asthma and COPD patients. Respir Med 2003; 97: 468-475.
5. Van Manen JG, Bindels PJ, Ijzermans CJ, Van Der Zee JS, Bottema BJ, Schade E. Prevalence of co-morbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epid 2001; 54: 287-293.
6. Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbation of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163: 1180-1186.
7. Fan VS, Curtis JR, Tu SP, McDonell MB, Fihn SD. Using quality of life to predict hospitalizations and mortality in patients with obstructive lung disease. Chest 2002; 122: 429-436
8. Soriano JB, Vestbo J, Pride NB, Kiri V, Maier WC. Survival in COPD patients after regular use of fluticisone proprionate and salmeterol in general practice. Eur Respir J 2002; 20: 819-825.
9. Almagro P. Calbo E. Ochoa de Echaguen A., et al. Mortality after hospitalization for COPD. Chest 2002; 121: 1441-8.
10. Yohannes AB, Baldwin RC, Connolly M. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age and Ageing 2002; 31: 137-140.
11. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-685.
12. Incalzi RA, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800.
13. Groenwgen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbations of COPD. Chest 2003; 124: 459-467.
14. Charlson ME, Pompei P, Ales KL, MacKenzie RC. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
15. Iezzoni LI. Dimensions of risk. In Iezzoni LI ed; Risk adjustment for measuring healthcare outcomes. 2nd ed. Chicago, Ill: Health Administration Press, 1997: 73-78.
16. Hulley SB, Martin JN, Cummings SR. Planning the measurements: precision and accuracy. In: Hulley SB, Cummings SR, Browner WS, Grady D, Hearst N, Newman TB eds. Designing Clinical Research 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001: 44.
17. Loh E. Prognosis of heart failure. In: UpToDate v10.2 Rose BD ed. Wellesley, MA: UpToDate, 2002.
18. Piccirillo, JF, Costas I, Claybour P, Borah AJ, Grove L. The measurement of co-morbidity by cancer registries, J Registry Management 2003; 30: 8-14.
19. Piccirillo JF. The impact of co-morbidity in head and neck cancer. J Registry Management 2001; 28: 173-175.
20. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. American Rev Respir Dis 1997; 136: 225-44.
21. Burrows B, Bloom JW, Gayle AT, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. NEJM 1987; 317: 1309-1314.
22. Burrows B. The course and prognosis of different types of chronic airflow limitation in a general population sample from Arizona: Comparison with the Chicago "COPD" series. Am Rev Respir Dis 1989; 140: S92-s94.
23. Meyer PA, Mannino DM, Redd SC, Olson DR. Characteristics of adults dying with COPD. Chest 2002; 122: 2003-2008.
24. Goel A, Pinckney RG, Littenberg B. APACHE II predicts long-term survival in COPD patients admitted to a general medical ward. J Gen Intern Med 2003; 18: 824-30.
25. Ancestry.com [Internet] Provo (Utah): MyFamily.com, Inc. Available from: http://www.ancestry.com/search/rectype/vital/ssdi/main.htm
26. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27: 387-404.
27. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrica 1994; 81: 515-526.
28. StataCorp. 1999. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation.
29. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. J Am Coll Cardiol 2001; 38: 1231-65.
30. Sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2446.
31. Gold MS, Aronson MD. Screening and diagnosis of patients with alcohol problems. In: UpToDate v10.2 Rose BD ed. Wellesley MA: UpToDate, 2002.
32. Alpert J. Risk stratification for cardiac events after acute myocardial infarction. In: UpToDate v10.2 Rose BD ed. Wellesley MA: UpToDate, 2002.
33. Bronson DL, Halperin AK, Marwick TH. Evaluating cardiac risk in noncardiac surgery patients. Cleve Clin J Med 1995; 62: 391-400.